Skip to main content

CVS Caremark TrueCost™

Redefining pharmacy pricing

Women professionals discussing content on a tablet.
Man looking through data

Innovating to give you the flexibility and transparency you need

For years, the pharmacy industry managed drug costs using two main strategies: 

  • Market basket pricing: where pricing is based on a mix of different medications to balance overall costs
  • Cross-subsidization: which offsets higher priced brand-name drugs with lower cost generic drugs

These approaches are no longer sustainable. Pharmacies, payors and their members all need pricing that more accurately reflects the actual cost of drugs. The marketplace is ready for transparent, innovative solutions.

Here's why we created TrueCost

Changing market dynamics and a strong focus on consumer needs demand bold pricing strategies. We're unmasking drug-level pricing to:

See true drug costs via acquisition-cost based pricing and drug-level rebate values to help you make smarter decisions to manage spend.

Multi-year, net cost guarantees for covered drugs across participating pharmacies protect your plan from market volatility.

By removing the incentive to shop around, members are more likely to stay on therapy, supporting better adherence and health outcomes.

Real results. Real scale.

Woman professional holding tablet.

93%

of our commercial book of business benefits from TrueCost features*

3.1M+

members benefit from 1 or more TrueCost features*

TrueCost may be an ideal fit if you're: 

  • Looking for acquisition-based pricing built on industry benchmarks

  • Seeking financial predictability through net cost guarantees

  • Using rebalanced prices to reduce members' incentive to shop off benefit

  • *FOR 93% OF OUR COMMERCIAL BOOK OF BUSINESS ALREADY BENEFITS FROM TRUECOST FEATURES CLAIM: The TrueCost features include rebalancing, drug-level rebates and the full TrueCost pricing model. CVS Health Analytics, 2026.

  • *FOR OVER 3.1M MEMBERS ALREADY BENEFIT FROM 1 OR MORE TRUECOST FEATURES SOURCE: CVS Health Analytics, 2026.